Literature DB >> 35610443

Physiological background parenchymal uptake of 18F-FDG in normal breast tissues using dedicated breast PET: correlation with mammographic breast composition, menopausal status, and menstrual cycle.

Yuri Shimizu1, Hiroko Satake1, Satoko Ishigaki2, Kazuhiro Shimamoto3, Fuga Uota1, Masanori Tadokoro4, Tomohiro Sato4, Katsuhiko Kato5, Tsuneo Ishiguchi4, Shinji Naganawa1.   

Abstract

OBJECTIVE: This study aimed to quantitatively evaluate the effects of age, mammographic density, menopausal status, and menstrual cycle on background parenchymal uptake (BPU) using ring-shaped dedicated breast positron emission tomography (dbPET).
METHODS: This study included 186 adult women who underwent mammography and dbPET on the same day and had no abnormalities classified as Breast Imaging Reporting and Data System (BI-RADS) category 1 on both examinations. The volume of interest (VOI) was placed in the glandular tissue of both breasts, and the maximum standardized uptake value (SUVmax), mean standardized uptake value (SUVmean), and metabolic breast volume (MBV) were measured as indicators of BPU. We analyzed the correlation between BPU and age, mammographic density, menopausal status, and menstrual cycle.
RESULTS: The SUVmax and SUVmean for normal breast tissue were inversely correlated with age (both p < 0.001). The SUVmax, SUVmean, and MBV of mammographically dense breast tissues were significantly higher than those of non-dense breast tissues (all p < 0.001). The SUVmax, SUVmean, and MBV of normal breast tissue in premenopausal women were significantly higher than those in postmenopausal women (p < 0.001, p < 0.001, p = 0.002, respectively). In the study, 59 premenopausal women, the SUVmax of normal breast tissue in the menstrual-follicular phase was significantly lower than that in the periovulatory-luteal phase (p = 0.02). When we sorted the premenopausal women by mammographic breast composition, the SUVmax and SUVmean of normal breast tissues in the menstrual-follicular phase were significantly lower than those in the periovulatory-luteal phase in the 44 premenopausal women with dense breasts (p = 0.007, and p = 0.038, respectively), whereas no statistically significant difference was found between the menstrual-follicular phase and the periovulatory-luteal phase in the 15 premenopausal women with non-dense breasts.
CONCLUSIONS: BPU in normal breast tissues assessed using ring-shaped dbPET was associated with mammographic density, menopausal status, and women's menstrual cycle. The menstrual cycle was significantly associated with BPU in premenopausal women with dense breasts but not in women with non-dense breasts.
© 2022. The Author(s) under exclusive licence to The Japanese Society of Nuclear Medicine.

Entities:  

Keywords:  Beast density; Breast; Dedicated breast positron emission tomography; Menstrual cycle; PET

Mesh:

Substances:

Year:  2022        PMID: 35610443     DOI: 10.1007/s12149-022-01754-4

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.258


  4 in total

Review 1.  Role of progesterone in normal breast physiology.

Authors:  L Speroff
Journal:  J Reprod Med       Date:  1999-02       Impact factor: 0.142

2.  Discussion on the alteration of 18F-FDG uptake by the breast according to the menstrual cycle in PET imaging.

Authors:  Hoon-Hee Park; Ji Yun Shin; Ju Young Lee; Gye Hwan Jin; Hyun Soo Kim; Kwang Yul Lyu; Tae Soo Lee
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2013

3.  Proliferation of normal breast epithelial cells as shown by in vivo labeling with bromodeoxyuridine.

Authors:  K Christov; K L Chew; B M Ljung; F M Waldman; L A Duarte; W H Goodson; H S Smith; B H Mayall
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

4.  Relationship between 18F-FDG uptake and breast density in women with normal breast tissue.

Authors:  Duska Vranjesevic; Christiaan Schiepers; Daniel H Silverman; Andrew Quon; James Villalpando; Magnus Dahlbom; Michael E Phelps; Johannes Czernin
Journal:  J Nucl Med       Date:  2003-08       Impact factor: 10.057

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.